Allotment of Equity Shares
Neuland Laboratories Ltd has informed BSE that the Board of Directors had allotted 2,300 fully paid up equity shares of a face value of Rs.10 each on July 17, 2014, to eligible employees pursuant to exercise of stock options granted under Employee Stock Option Scheme, 2008.Consequently w.e.f. July 17, 2014, the paid-up equity capital of the Company stands increased to Rs.7,65,79,780 from Rs.7,65,56,780. Shareholding Pattern For June 30, 2014
Neuland Laboratories Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014. Closure of Trading Window
Neuland Laboratories Ltd has informed BSE that a meeting of Board of Directors of the Company will be held on August 01, 2014, inter alia, to consider and take on record the un-audited financial results of the Company for the quarter ended June 30, 2014.Further, as per the provisions of the Code of Conduct for Prevention of insider Trading of the Company, the Trading Window for transactions in shares of the Company is closed from July 17,... Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neuland Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Outcome of AGM
Neuland Laboratories Ltd has informed BSE that the 30th Annual General Meeting (AGM) of the Company was held on June 24, 2014. Newspaper publication of the corrigendum to the Annual Report
With reference to the Annual Report 2013-14, Neuland Laboratories Ltd has now submitted to BSE a copy of the newspaper publication of the corrigendum to the Annual Report. Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neuland Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Fixes Book Closure for Dividend & AGM
Neuland Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from June 18, 2014 to June 24, 2014 (both days inclusive) for the purpose of Payment of Dividend & 30th Annual General Meeting (AGM) of the Company to be held on June 24, 2014. Cessation of Director
Neuland Laboratories Ltd has informed BSE that Mr. Shashi Bhushan Budhiraja has resigned from the Board of Directors effective from May 09, 2014 due to personal reasons. Outcome of Board Meeting
Neuland Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 09, 2014, had appointed Mrs. Bharati Rao as an Additional Director on the Board of the Company effective May 09, 2014.